Investigating a new type of immune cell in brain autoimmune diseases
ThGM Cells in CNS Autoimmunity
This study is looking at a special type of immune cell that makes a protein linked to multiple sclerosis, and it's for people with MS to help us understand how these cells might play a role in the disease and find new ways to treat it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10653198 on NIH RePORTER |
What this research studies
This research focuses on a newly identified subset of immune cells called ThGM cells, which produce a specific protein (GM-CSF) and are found in higher numbers in patients with multiple sclerosis (MS). The study aims to understand the origin and role of these cells in autoimmune conditions affecting the central nervous system (CNS). By analyzing blood and cerebrospinal fluid samples from patients, researchers hope to clarify how ThGM cells contribute to the development of CNS autoimmunity. This could lead to new insights into the mechanisms of diseases like MS and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with multiple sclerosis or other CNS autoimmune diseases.
Not a fit: Patients with autoimmune conditions not affecting the CNS or those without a diagnosis of autoimmune diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with autoimmune diseases affecting the brain.
How similar studies have performed: While the role of ThGM cells in CNS autoimmunity is minimally studied, similar research approaches have shown promise in understanding immune cell functions in other autoimmune diseases.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Rostami, A.m. — Thomas Jefferson University
- Study coordinator: Rostami, A.m.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.